🔥🚀 Dan Ives calls for $600, RBC and Deutsche Bank give $500—when Wall Street collectively raises $Tesla(TSLA.US)'s target price, they are rewriting the valuation model.

While the market is still debating whether "EV demand has peaked," Wall Street's core analysts are already discussing another matter—

$Tesla(TSLA.US)

Is it being redefined?

The latest round of institutional views shows rare consistency:

Benchmark (Mickey Legg)—Buy, target price $475

RBC Capital Markets—Buy, target price $500

Deutsche Bank—Buy, target price $500

Baird (Ben Kallo)—Buy, target price $548

Tigress Financial—Buy, target price $550

Dan Ives (Wedbush)—Buy, target price $600

This is not simple "bullishness."

This is a migration of the valuation framework.

Benchmark calls 2026 the "investment year," believing capital expenditure will accelerate deployment in autonomous driving, AI, robotics, and energy systems, while maintaining resilient profit margins.

RBC focuses on the increase in Capex and the advancement of the Robotaxi timeline, seeing it as a signal of future revenue structure changes.

Deutsche Bank mentions a key concept—the "Physical AI era," suggesting Tesla is building a real-world AI platform.

Dan Ives is even more aggressive, giving a $600 target price, believing the market underestimates the long-term value revaluation brought by autonomous driving and robotics.

Baird even extends the model to 2027, expecting paid Robotaxi and the commercialization of Optimus to begin forming revenue curves.

The consensus of these institutions is not:

🚗 A rebound in car sales

But rather:

🤖 Commercialization of autonomous driving

🧠 Real-world AI deployment

🚕 Formation of a Robotaxi network

🤖 Optimus opening new revenue dimensions

This means the valuation logic is shifting from "hardware profits" to "platform cash flow."

But I'm more concerned about one question:

Are the prerequisites for these target prices already in place?

They imply four assumptions:

Autonomous driving can be deployed at scale.

Robotaxi gains regulatory support.

Optimus has mass-production capability.

Gross margin is not eroded by price wars.

If any one of these is delayed, the valuation reconstruction will be postponed.

The key now is not "expensive or not."

But rather:

Has the market already priced in the Physical AI era in advance?

If 2026 is the year of capital investment and 2027 is the year of realization, then we are only in the early stage of valuation expansion.

If the realization pace is slower than expected, $600 will become a distant story.

The variables I'm watching are clear:

Capex pace

FSD data

Regulatory attitude

Robotics progress

These four signals will determine whether this round of upgrades is forward-looking positioning or emotional expansion.

Do you think this round of target price increases is the start of a cycle, or a premature valuation overdraw?

📬 I will continue to track institutional rating changes and signals of valuation model migration. If you care about more than just price movements, but structural inflection points, welcome to subscribe.